-
公开(公告)号:US20080273660A1
公开(公告)日:2008-11-06
申请号:US12103573
申请日:2008-04-15
申请人: William S. Dynan , Shuyi Li , Yoshihiko Takeda
发明人: William S. Dynan , Shuyi Li , Yoshihiko Takeda
IPC分类号: A61N5/10 , A61K39/395 , C12N5/06 , C12N13/00 , A61P31/00
CPC分类号: C07K16/40 , A61K38/00 , A61K2039/505 , C07K2317/565 , C07K2317/622 , C07K2317/73 , C07K2317/76 , C07K2317/82 , G01N33/502 , G01N2500/20
摘要: Compositions and methods for modulating a DNA repair process in vivo or in vitro are provided. One aspect of the disclosure provides a pharmaceutical composition including a DNA repair modulator. The DNA repair modulator includes, but is not limited to, compositions such as polypeptides, for example antibodies; modified polypeptides; and branched or unbranched aliphatic, cycloaliphatic, substituted aliphatic, aromatic hydrocarbons, or heterocyclic carbon-based compounds that associate with a DNA repair polypeptide, for example, DNA-PKcs.
摘要翻译: 提供了用于在体内或体外调节DNA修复过程的组合物和方法。 本公开的一个方面提供了包含DNA修复调节剂的药物组合物。 DNA修复调节剂包括但不限于诸如多肽的组合物,例如抗体; 修饰的多肽; 以及与DNA修复多肽例如DNA-PKcs缔合的支链或非支链脂族,脂环族取代的脂族,芳族烃或杂环碳基化合物。
-
2.
公开(公告)号:US08535725B2
公开(公告)日:2013-09-17
申请号:US13349792
申请日:2012-01-13
申请人: Shuyi Li , William S. Dynan , George Wicks , Steven Serkiz
发明人: Shuyi Li , William S. Dynan , George Wicks , Steven Serkiz
IPC分类号: A61K9/50 , A61K51/12 , A61K31/721
CPC分类号: A61K9/50 , A61K9/0019 , A61K9/501 , A61K9/5036 , A61K31/721 , A61K51/1286
摘要: The present invention includes compositions of porous-wall hollow glass microspheres and one or more biomolecules, wherein the one or more biomolecules are positioned within a void location within the hollow glass microsphere, and the use of such compositions for the diagnostic and/or therapeutic delivery of biomolecules.
摘要翻译: 本发明包括多孔壁中空玻璃微球和一种或多种生物分子的组合物,其中所述一种或多种生物分子位于中空玻璃微球内的空隙位置内,以及使用这种组合物进行诊断和/或治疗递送 的生物分子。
-
公开(公告)号:US20120201892A1
公开(公告)日:2012-08-09
申请号:US13349792
申请日:2012-01-13
申请人: Shuyi Li , William S. Dynan , George Wicks , Steven Serkiz
发明人: Shuyi Li , William S. Dynan , George Wicks , Steven Serkiz
IPC分类号: A61K9/14 , A61K31/711 , A61K31/713 , A61K38/18 , A61K35/76 , A61K39/395 , A61K38/22
CPC分类号: A61K9/50 , A61K9/0019 , A61K9/501 , A61K9/5036 , A61K31/721 , A61K51/1286
摘要: The present invention includes compositions of porous-wall hollow glass microspheres and one or more biomolecules, wherein the one or more biomolecules are positioned within a void location within the hollow glass microsphere, and the use of such compositions for the diagnostic and/or therapeutic delivery of biomolecules.
摘要翻译: 本发明包括多孔壁中空玻璃微球和一种或多种生物分子的组合物,其中所述一种或多种生物分子位于中空玻璃微球内的空隙位置内,以及使用这种组合物进行诊断和/或治疗递送 的生物分子。
-
公开(公告)号:US08058612B2
公开(公告)日:2011-11-15
申请号:US12698065
申请日:2010-02-01
摘要: Improved radiation devices and their associated fabrication and applications are described herein. The microirradiators generally include a non-radioactive conducting electrode, an insulating sheath, a radioactive source, and, optionally, a contact electrode. The microirradiators generally produce low absolute radiation levels with high radiation flux densities.
摘要翻译: 本文描述了改进的辐射装置及其相关的制造和应用。 微型辐射器通常包括非放射性导电电极,绝缘护套,放射源和任选的接触电极。 微辐射器通常产生具有高辐射通量密度的低绝对辐射水平。
-
公开(公告)号:US20100200771A1
公开(公告)日:2010-08-12
申请号:US12698065
申请日:2010-02-01
摘要: Improved radiation devices and their associated fabrication and applications are described herein. The microirradiators generally include a non-radioactive conducting electrode, an insulating sheath, a radioactive source, and, optionally, a contact electrode. The microirradiators generally produce low absolute radiation levels with high radiation flux densities.
摘要翻译: 本文描述了改进的辐射装置及其相关的制造和应用。 微电子机通常包括非放射性导电电极,绝缘护套,放射源和任选的接触电极。 微辐射器通常产生具有高辐射通量密度的低绝对辐射水平。
-
公开(公告)号:US06441158B1
公开(公告)日:2002-08-27
申请号:US09223139
申请日:1998-12-30
申请人: William S. Dynan , Sunghan Yoo
发明人: William S. Dynan , Sunghan Yoo
IPC分类号: C07H2104
CPC分类号: C12N15/1137 , A61K38/00 , C12N2310/18 , C12N2310/53
摘要: Disclosed are oligomers that bind Ku protein. These oligomers are useful for inhibiting activation of DNA-PK, treating certain forms of autoimmune disease, detection and purification of Ku protein, and identification of proteins that interact with Ku protein. Preferably, the oligomers are composed of nucleotides, nucleotide analogs, or a combination. Most preferably, the oligomers are composed of ribonucleotides. Also disclosed is a method of inhibiting DNA repair, a method of identifying cellular proteins that interact with Ku protein, and a method of treating autoimmune disease in patients with anti-Ku antibodies. The disclosed oligomers can have several preferred features, either alone or in combination, in addition to Ku binding. One such feature, referred to herein as inhibition activity, is inhibition of DNA-PK kinase activity. Another preferred feature, referred to herein as aptamer motifs, is the presence of one or more of the base sequences GCUUUCCCANNNAC, A(A/C)AUGA, and AACUUCGA. These sequences—referred to herein as aptamer motif 1, aptamer motif 2, and aptamer motif 3, respectively—are associated with Ku binding capability. Another preferred feature, referred to herein as aptamer structure, is the presence of a structure similar to the structure shown in FIG. 6A. This structure has the general formula 5′-A-B-C-D-C′-E-A′-3′, where A, B, C, D, C′, E, and A′ are components of the oligomer. In this structure, A and A′ interact to form a stem structure, C and C′ interact to form a stem structure, B and E make up a bulge region, and D is either a bulge or a loop. FIG. 6A depicts component D as a loop. Each of these preferred features (inhibition activity, aptamer motif, and aptamer structure) can be used either alone or in combination with one or both of the other characteristics.
摘要翻译: 公开了结合Ku蛋白的寡聚体。 这些寡聚体可用于抑制DNA-PK的活化,治疗某些形式的自身免疫疾病,Ku蛋白的检测和纯化,以及与Ku蛋白相互作用的蛋白质的鉴定。 优选地,寡核苷酸由核苷酸,核苷酸类似物或组合组成。 最优选地,寡聚体由核糖核苷酸组成。 还公开了抑制DNA修复的方法,鉴定与Ku蛋白相互作用的细胞蛋白质的方法以及在抗Ku抗体患者中治疗自身免疫疾病的方法。 除了Ku结合之外,所公开的低聚物可以具有单独或组合的几个优选特征。 这里称为抑制活性的一个这样的特征是抑制DNA-PK激酶活性。 碱基序列GCUUUCCCANNNAC,A(A / C)AUGA和AACUUCGA中存在一个或多个碱基序列的另一优选特征。 这些序列 - 分别称为适体基序1,适体基序2和适体基序3 - 与Ku结合能力相关。 在本文中称为适体结构的另一个优选特征是存在类似于图1所示结构的结构。 6A。 该结构具有通式5'-A-B-C-D-C'-E-A'-3',其中A,B,C,D,C',E和A'是低聚物的组分。 在这种结构中,A和A'相互作用以形成茎结构,C和C'相互作用形成茎结构,B和E组成一个凸起区域,D是一个凸起或一个环。 图。 图6A将部件D描绘为循环。 这些优选特征(抑制活性,适体基序和适体结构)中的每一个可以单独使用或与一种或两种其它特征组合使用。
-
-
-
-
-